Cited by 11Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Implementing the 2013 WHO diagnostic criteria for gestational diabetes mellitus in a Rural Nigerian Population

Open access
Olumodeji, Ayokunle Moses, Okere, Raymond Akujuobi, Adebara, Idowu Oluwaseyi, Ajani, Gbadebo Oladimeji, Ajani, Gbadebo Oladimeji, Adewara, Olumide Emmanuel, Ghazali, Segun Murtala, Olumodeji, Ufuoma Oluwaseyi·2020·Pan African Medical Journal

Abstract

INTRODUCTION: the World Health Organization (WHO) reviewed the threshold values required for the diagnosis of Gestational Diabetes Mellitus (GDM) in 2013 and the implementation of the new diagnostic criteria have been associated with increase in the prevalence of GDM in some populations. The new cohort of pregnant women that will be labeled to have GDM by the 2013 WHO diagnostic criteria but not by the 1999 WHO diagnostic criteria will pose additional burden to specialized antenatal care, though their pregnancy outcome may not warrant such care. It is thus important to first determine the effect of the implementation of these new consensus diagnostic criteria on the prevalence of GDM in our environment. METHODS: this is a prospective hospital-based study that compared the implementation of both 1999 and 2013 WHO GDM diagnostic criteria among 117 pregnant women who were initially screened with 50-gram Glucose Challenge Test (50-g GCT). Women with a positive Glucose Challenge Test (GCT) result underwent a 75-gram Oral Glucose Tolerance Test (75-g OGTT), which was used as the actual diagnostic test for GDM using both 2013 WHO and 1999 WHO diagnostic criteria. Associations between variables were tested using Chi-square, Fisher's exact and t-test as appropriate. Significance level was set at P value < 0.05. RESULTS: the prevalence rates of GDM in the study were 2.6% and 7.7% for 1999 WHO and 2013 WHO criteria respectively. Clinical characteristics were similar in women with GDM and women without GDM. The fasting component of the OGTT identified all the women with GDM. CONCLUSION: the implementation of the 2013 WHO diagnostic criteria is associated with a 2.5 to 3-fold rise in the prevalence of GDM. Selective risk-factor based screening may be clinically irrelevant with the adoption of the 2013 WHO diagnostic criteria. A minimum of fasting plasma glucose in resource poor settings can be considered to identify women with GDM since it appeared to have 100% sensitivity in our study.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.11604/pamj.2020.36.208.20818

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • For all studies in Africa, the gestational diabetes mellitus prevalence was higher, as confirmed by Olumodeji et al.

    “One thing was obvious: for all of the studies, the GDM prevalence was higher, which was confirmed by Olumodeji et al. [33].”

    From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [33]

    The Discussion reports higher GDM prevalence under the 2013 WHO criteria in this rural Nigerian study and in an Ekiti study. It does not confirm a higher prevalence for all African studies: it notes that a study in Jos, Nigeria found no significant difference between the 1999 and 2013 criteria. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 16

  1. [1]Divakar H Manyonda I Battling with the rising prevalence of gestational diabetes mellitus: screening and diagnosis International Journal of Infertility and Fetal Medicine 2011 2 96 100
  2. [2]World Health Organization Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy 2013 Geneva WHO Contract No: WHO_NMH_MND_13.2_eng 24199271
  3. [3]Katreddy MV Pappachan JM Taylor SE Nevill AM Indusekhar R Nayak AU Hemoglobin A1c in early postpartum screening of women with gestational diabetes World J Diabetes 2013 6 15 4 3 76 81 23772276 PMC3680627
  4. [4]Caprio S Development of type 2 diabetes mellitus in the obese adolescent: a growing challenge Endocr Pract 2012 Sep-Oct 18 5 791 5 23047931
  5. [5]Coppell K Mann J Williams S Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 Adult Nutrition Survey NZ Med J 2013 3 1 126 1370 23 42 23474511
  6. [6]Kuti MA Abbiyesuku FM Akinlade KS Akinosun OM Adedapo KS Adeleye JO et al Oral glucose tolerance testing outcomes among women at high risk for gestational diabetes mellitus J Clin Pathol 2011 8 64 8 718 21 21606228
  7. [7]National Institute for Health and Care Excellence Diabetes in pregnancy: management from preconception to the postnatal period 2015 NICE guideline No 1 London NICE 32212588
  8. [8]Cundy T Ackermann E Ryan EA Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear BMJ 2014 3 11 348 g1567 24618099
  9. [10]McIntyre HD Metzger BE Coustan DR Dyer AR Hadden DR Hod M et al Counterpoint: Establishing Consensus in the Diagnosis of GDM Following the HAPO Study Curr Diab Rep 2014 6 14 6 497 24777652 PMC4039030
  10. [11]Trinder P Determination of Blood glucose using an Oxidase-Peroxidase System with a Non-carcinogenic Chromogen J Clin Pathol 1969 3 22 2 158 61 5776547 PMC474026
  11. [12]Anzaku AS Musa J Prevalence and associated risk factors for gestational diabetes in Jos, North-central, Nigeria Archives of gynecology and obstetrics 2013 5 287 5 859 63 23224650
  12. [13]Olagbuji BN Atiba AS Olofinbiyi BA Akintayo AA Awoleke JO Ade-Ojo IP et al Prevalence of and risk factors for gestational diabetes using 1999, 2013 WHO and IADPSG criteria upon implementation of a universal one-step screening and diagnostic strategy in a sub-Saharan African population European Journal of Obstetrics and Gynecology and Reproductive Biology 2015 6 189 27 32 25855324
  13. [14]American Diabetes Association Report of the expert committe on the diagnosis and classification of diabetes mellitus Diabetes Care 2003 1 26 Suppl 1 S5 20 12502614
  14. [15]Moses RG Morris GJ Petocz P San Gil F Garg D The impact of potential new diagnostic criteria on the prevalence of gestational diabetes mellitus in Australia Med J Aust 2011 4 4 194 7 338 40 21470082
  15. [16]Zhu W Yang H Wei Y Wang Z Li X Wu H et al Comparing the Diagnostic Criteria for gestational diabetes mellitus of World Health Organization 2013 with 1999 in Chinese Population Chinese Medical Journal 2015 1 5 128 1 125 7 25563325 PMC4837807
  16. [17]Trujillo J Vigo A Reichelt A Duncan BB Schmidt MI Fasting plasma glucose to avoid a full OGTT in the diagnosis of gestational diabetes Diabetes Research and Clinical Practice 2014 9 105 3 322 6 25037441

Cited by

Sorted by citations

Authors
Olumodeji, A. M., Okere, R. A., Adebara, I. O., Ajani, G. O., Ajani, G. O., Adewara, O. E., Ghazali, S. M., & Olumodeji, U. O.
Affiliations
Lagos University Teaching Hospital (NG)
Corresponding author
Olumodeji, Ayokunle Moses
Venue
Pan African Medical Journal
Published
2020
Volume
36
Pages
208-208
ISSN
1937-8688 (ISSN-L)
OpenAlex
W3045137693
Cited by
11
References
0
Citations by year
2026: 2 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 1
FWCI
0.92
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Pan African Medical Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, GDM prevalence, oral glucose tolerance test, glucose challenge test, fasting blood glucose, prenatal screening, resource-limited settings, rural Nigeria
MeSH terms
Adult, Female, Glucose Tolerance Test, Humans, Mass Screening, Nigeria, Pregnancy, Prenatal Care, Prospective Studies, Risk Factors, Rural Population, World Health Organization, Cohort Studies, Prevalence, Diabetes, Gestational, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review